Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ARIC P ADAOAG

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1003262296
CMS profile
11148552
Location
LAS VEGAS, NV

General Payments · PY2021–2024

$3,149.67

  • Reported across 117 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$679.34

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $679.34 36

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Amgen Inc. $237.68 13
Acerta Pharma LLC $154.66 7
Lilly USA, LLC $133.76 8
Boehringer Ingelheim Pharmaceuticals, Inc. $53.78 3
Daiichi Sankyo Inc. $37.20 2
Lucid Diagnostics Inc. $24.91 1
Exact Sciences Corporation $19.20 1
Novo Nordisk AS $18.15 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $1,799.02 45
PY2022 $353.31 18
PY2023 $318.00 18
PY2024 $679.34 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $18.40 01/12/2024 Food and Beverage Undisputed 01/23/2026 1117489328 CMS
Amgen Inc. $14.47 03/04/2024 Food and Beverage Undisputed 01/23/2026 1117489330 CMS
Amgen Inc. $27.86 04/12/2024 Food and Beverage Undisputed 01/23/2026 1117489332 CMS
Amgen Inc. $13.06 05/02/2024 Food and Beverage Undisputed 01/23/2026 1115409443 CMS
Amgen Inc. $16.07 05/24/2024 Food and Beverage Undisputed 01/23/2026 1117489334 CMS
Amgen Inc. $8.86 06/10/2024 Food and Beverage Undisputed 01/23/2026 1117489336 CMS
Amgen Inc. $25.26 07/29/2024 Food and Beverage Undisputed 01/23/2026 1117489338 CMS
Amgen Inc. $19.23 08/16/2024 Food and Beverage Undisputed 01/23/2026 1115409431 CMS
Amgen Inc. $20.20 09/13/2024 Food and Beverage Undisputed 01/23/2026 1117489340 CMS
Amgen Inc. $19.43 10/11/2024 Food and Beverage Undisputed 01/23/2026 1115409435 CMS
Amgen Inc. $21.02 11/08/2024 Food and Beverage Undisputed 01/23/2026 1117489342 CMS
Amgen Inc. $22.25 12/05/2024 Food and Beverage Undisputed 01/23/2026 1115409427 CMS
Amgen Inc. $11.57 12/11/2024 Food and Beverage Undisputed 01/23/2026 1115409440 CMS
AstraZeneca Pharmaceuticals LP $16.74 02/12/2024 Food and Beverage Undisputed 01/23/2026 1104355356 CMS
AstraZeneca Pharmaceuticals LP $23.70 04/03/2024 Food and Beverage Undisputed 01/23/2026 1104423147 CMS
AstraZeneca Pharmaceuticals LP $23.34 04/25/2024 Food and Beverage Undisputed 01/23/2026 1104390477 CMS
AstraZeneca Pharmaceuticals LP $35.14 05/03/2024 Food and Beverage Undisputed 01/23/2026 1104654195 CMS
AstraZeneca Pharmaceuticals LP $14.02 06/05/2024 Food and Beverage Undisputed 01/23/2026 1105338885 CMS
AstraZeneca Pharmaceuticals LP $22.17 07/10/2024 Food and Beverage Undisputed 01/23/2026 1104537164 CMS
AstraZeneca Pharmaceuticals LP $19.55 07/17/2024 Food and Beverage Undisputed 01/23/2026 1105763920 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.74 05/09/2024 Food and Beverage Undisputed 01/23/2026 1117831926 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.59 08/22/2024 Food and Beverage Undisputed 01/23/2026 1117831922 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.45 10/29/2024 Food and Beverage Undisputed 01/23/2026 1117831924 CMS
Daiichi Sankyo Inc. $22.95 07/20/2024 Food and Beverage Undisputed 01/23/2026 1089391028 CMS
Daiichi Sankyo Inc. $14.25 10/25/2024 Food and Beverage Undisputed 01/23/2026 1089391026 CMS
Exact Sciences Corporation $19.20 01/30/2024 Food and Beverage Undisputed 01/23/2026 1114540589 CMS
Lilly USA, LLC $23.68 02/23/2024 Food and Beverage Undisputed 01/23/2026 1135576680 CMS
Lilly USA, LLC $17.33 04/22/2024 Food and Beverage Undisputed 01/23/2026 1135518276 CMS
Lilly USA, LLC $3.02 04/22/2024 Food and Beverage Undisputed 01/23/2026 1135551211 CMS
Lilly USA, LLC $13.09 04/22/2024 Food and Beverage Undisputed 01/23/2026 1135576682 CMS
Lilly USA, LLC $27.50 07/11/2024 Food and Beverage Undisputed 01/23/2026 1135558664 CMS
Lilly USA, LLC $21.61 07/22/2024 Food and Beverage Undisputed 01/23/2026 1135538151 CMS
Lilly USA, LLC $8.06 10/08/2024 Food and Beverage Undisputed 01/23/2026 1135538148 CMS
Lilly USA, LLC $19.47 12/16/2024 Food and Beverage Undisputed 01/23/2026 1135562410 CMS
Lucid Diagnostics Inc. $24.91 08/20/2024 Food and Beverage Undisputed 01/23/2026 1152302733 CMS
Novo Nordisk Inc $18.15 02/19/2024 Food and Beverage Undisputed 01/23/2026 1100353748 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.